Metrics other than potency reveal systematic variation in responses to cancer drugs - Dataset (ID:20120)
Small Molecules Studied
Download: Excel (XLSX), Comma-separated (CSV), Images (Zip file)
| HMS LINCS ID | Name | Alternative Names | LINCS ID | Structure Image | PubChem CID |
|---|---|---|---|---|---|
| 10261-1 | Ixabepilone | Azaepothilone B; Ixempra | LSM-43293 |  | 216344 |
| 10133-2 | Afatinib | BIBW-2992 | LSM-43226 |  | 57519523 |
| 10258-1 | Ibandronate | Boniva | LSM-4279 |  | 44828485 |
| 10245-1 | Cisplatin | CDDP; cis-Diaminodichloroplatinum; Cisplatinum; Lederplatin; Briplatin; Cismaplat | LSM-4268 |  | |
| 10230-2 | Lestaurtinib | CEP-701 | LSM-1231 |  | 126565 |
| 10346-1 | Valproic acid | Depakine | LSM-4620 |  | 3549980 |
| 10249-1 | Epirubicin | Ellence | LSM-2078 |  | 41867 |
| 10269-1 | Oxaliplatin | Eloxatin | LSM-44941 |  | 5310940 |
| 10238-1 | 5-FU | Fluorouracil | LSM-4261 |  | 3385 |
| 10252-1 | Gemcitabine | Gemzar | LSM-5333 |  | 60750 |
| 10023-3 | Imatinib | Gleevec; Glivec; CGP-57148B; STI-571 | LSM-1023 |  | 5291 |
| 10142-2 | Trametinib | GSK-1120212; GSK1120212; GSK1120212B; JTP-74057 | LSM-1143 |  | 11707110 |
| 10146-2 | Omipalisib | GSK2126458; GSK2126458A | LSM-1147 |  | 25167777 |
| 10013-3 | GSK461364 | GSK461364A | LSM-1013 |  | 15983966 |
| 10278-1 | Topotecan | Hycamtin | LSM-5662 |  | 60700 |
| 10246-1 | CPT-11 | Irinotecan | LSM-2167 |  | 60838 |
| 10035-2 | Sigma A6730 | KIN001-102; AKT inhibitor VIII; Akt1/2 kinase inhibitor | LSM-1035 |  | 10196499 |
| 10062-3 | GSK1070916 | KIN001-216 | LSM-1062 |  | 46885626 |
| 10348-1 | Z-Leu-Leu-Norvalinal | MG-115 | LSM-6358 |  | 9868928 |
| 10265-1 | Pevonedistat | MLN 4924; MLN-4924; MLN4924 | LSM-6263 |  | 16720766 |
| 10281-1 | Vinorelbine | Navelbine | LSM-6302 |  | 5311497 |
| 10097-3 | Erlotinib | OSI-774 | LSM-1097 |  | 176870 |
| 10102-3 | Taxol | Paclitaxel | LSM-1102 |  | 441276 |
| 10263-1 | LBH589 | Panobinostat | LSM-4284 |  | 57519507 |
| 10243-1 | CGC-11047 | PG11047 | LSM-4266 |  | 476863 |